Company intelligence / Profile preview

Archetype BioMedical

London, Ontario, Canadaacademic.oup.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Archetype BioMedical develops advanced, patient-specific cardiac surgical simulators, including the CarmoSIM™ ADVANCED Surgery Trainer. Their products are used worldwide for realistic training in minimally invasive mitral and aortic valve surgeries. The company has published peer-reviewed research demonstrating the sophistication and clinical relevance of their models for both education and preoperative planning.

Therapeutic areas: Cardiovascular
Modalities: Device (surgical simulators)Simulation-based training tools
Industry: Surgical Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Archetype BioMedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Archetype BioMedical.

Explore the full profile